Fifth Third Bancorp »

4d Molecular Therapeutics In shares owned by Fifth Third Bancorp

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Fifth Third Bancorp from 13F filings

Historical chart of Fifth Third Bancorp investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Fifth Third Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Fifth Third Bancorp

Quarter filed Position value Share count Share price at filing
2026-03-31 $326 35 9.31
2025-06-30 $408 110 3.71

More positions owned by Fifth Third Bancorp

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr S&p 100 Etf (OEF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Fifth Third Bancorp

Top funds holding 4d Molecular Therapeutics In

Henderson Group
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
BVF
State Street Corporation
Armistice Capital
Federated Investors
Trails Edge Capital Partners
Adage Capital Partners GP
Geode Capital Management
Bank of America Corporation
Evergreen Quality Fund GP

View all funds holding 4d Molecular Therapeutics In